论文部分内容阅读
目的:分析硝苯地平、厄贝沙坦联合治疗糖尿病合并高血压患者的效果。方法:选取我院糖尿病合并高血压患者96例(2016年10月12日到2017年5月12日期间),将其依据随机数字表法分组原则,分为对照组(硝苯地平为主治疗)、观察组(再联合使用厄贝沙坦),各48例,对比2组的治疗效果和临床各项指标情况。结果:观察组糖尿病合并高血压患者的总有效率高达93.75%,且24h尿微量清蛋白数据、血压指标改善明显,和对照组相比,前者处于优势地位,P<0.05。结论:在使用硝苯地平的基础上,针对糖尿病合并高血压患者再联合实施厄贝沙坦的方案治疗,其效果更为理想,具有一定的应用价值。
Objective: To analyze the effect of combination of nifedipine and irbesartan on patients with diabetes and hypertension. Methods: Ninety-six patients with diabetes mellitus and hypertension in our hospital (from October 12, 2016 to May 12, 2017) were randomly divided into control group (nifedipine-based treatment) ), The observation group (combined with irbesartan), each 48 cases, the treatment of two groups compared with the clinical indicators of the situation. Results: The total effective rate was 93.75% in the observation group with diabetes mellitus complicated with hypertension, and the 24h urine microalbumin data and the blood pressure index improved obviously. The former was in a predominant position, P <0.05. Conclusion: Based on the use of nifedipine, the combination therapy with irbesartan in patients with diabetes mellitus complicated with hypertension is more effective and has a certain value of application.